Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-25 @ 4:58 AM
NCT ID:
NCT00889018
Eligibility Criteria:
Inclusion Criteria:
* All new cases of retinoblastoma with group C or D tumor as per the ICRB (International classification of retinoblastoma, Table 2) that present at Rajendra Prasad Centre for Ophthalmic Sciences over first 2 years of the study period
Exclusion Criteria:
* Biomicroscopic evidence of iris neovascularization
* Neovascular glaucoma
* Tumor invasion into the anterior chamber, iris, optic nerve, choroid, or extraocular tissues as documented by clinical, ultrasonographic, and neuroimaging modalities.
* Systemic exclusion criteria include:
* evidence of systemic metastasis
* prior chemotherapy
* prior treatment for retinoblastoma, or
* inadequate renal or hepatic function
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00889018
Study Brief:
Protocol Section:
NCT00889018